blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1993593

EP1993593 - PHARMACEUTICAL COMPOSITIONS COMPRISING SODS AND GLIADIN BASED PEPTIDE FRAGMENTS [Right-click to bookmark this link]
Former [2008/48]PHARMACEUTICAL COMPOSITIONS COMPRISING SODS AND PROLAMINE BASED PEPTIDE FRAGMENTS
[2013/11]
StatusNo opposition filed within time limit
Status updated on  01.07.2016
Database last updated on 19.10.2024
Most recent event   Tooltip17.08.2018Lapse of the patent in a contracting state
New state(s): BG
published on 19.09.2018  [2018/38]
Applicant(s)For all designated states
Isocell S.A.
53, boulevard du Général Martial Valin
75015 Paris / FR
[2015/33]
Former [2008/48]For all designated states
Isocell Pharma S.A.
53, Boulevard du GeneralMartial Valin
75015 Paris / FR
Inventor(s)01 / CALENDA, Alphonse
16 rue Monplaisir
F-49124 Le Plessis Grammoire / FR
 [2008/48]
Representative(s)Thurgood, Alexander John, et al
IP Galore
4, rue Durette
63500 Brenat / FR
[N/P]
Former [2010/16]Thurgood, Alexander John, et al
IP Galore 4, rue Durette
63500 Brenat / FR
Former [2008/48]Thurgood, Alexander John, et al
Cabinet Richebourg "Le Clos du Golf" 69, rue Saint-Simon
42000 Saint-Etienne / FR
Application number, filing date06727320.115.03.2006
[2008/48]
WO2006IB00577
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2007105024
Date:20.09.2007
Language:EN
[2007/38]
Type: A1 Application with search report 
No.:EP1993593
Date:26.11.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 20.09.2007 takes the place of the publication of the European patent application.
[2008/48]
Type: B1 Patent specification 
No.:EP1993593
Date:26.08.2015
Language:EN
[2015/35]
Search report(s)International search report - published on:EP20.09.2007
ClassificationIPC:A61K38/44, C12N9/02, A61K38/16, C07K16/40, A61P29/00
[2014/50]
CPC:
A61K38/446 (EP,US); A61K38/168 (EP,US); A61P29/00 (EP);
A61P35/00 (EP); A61P39/06 (EP); A61P9/00 (EP);
A61P9/10 (EP); C07K16/40 (EP,US); C12N9/0089 (EP,US);
C07K2319/00 (EP,US) (-)
C-Set:
A61K38/168, A61K2300/00 (US,EP);
A61K38/446, A61K2300/00 (EP,US)
Former IPC [2013/11]A61K38/16, A61K38/44, C07K16/40, C12N9/00, A61P29/00
Former IPC [2008/48]A61K38/44, C12N9/00, A61K39/395, A61P29/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2015/35]
Former [2008/48]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:SOD UND PEPTIDFRAGMENTE AUF GLIADINBASIS ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN[2013/11]
English:PHARMACEUTICAL COMPOSITIONS COMPRISING SODS AND GLIADIN BASED PEPTIDE FRAGMENTS[2013/11]
French:COMPOSITIONS PHARMACEUTIQUE COMPRENANT DES SOD ET DES FRAGMENTS PEPTIDIQUES À BASE DE GLIADINE[2013/11]
Former [2008/48]SOD UND PEPTIDFRAGMENTE AUF PROLAMINBASIS ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN
Former [2008/48]PHARMACEUTICAL COMPOSITIONS COMPRISING SODS AND PROLAMINE BASED PEPTIDE FRAGMENTS
Former [2008/48]COMPOSITIONS PHARMACEUTIQUE COMPRENANT DES SOD ET DES FRAGMENTS PEPTIDIQUES À BASE DE PROLAMINE
Entry into regional phase01.09.2008National basic fee paid 
01.09.2008Designation fee(s) paid 
01.09.2008Examination fee paid 
Examination procedure01.09.2008Examination requested  [2008/48]
08.02.2010Despatch of a communication from the examining division (Time limit: M04)
01.10.2010Reply to a communication from the examining division
10.12.2010Despatch of a communication from the examining division (Time limit: M06)
19.06.2011Reply to a communication from the examining division
21.12.2011Despatch of a communication from the examining division (Time limit: M06)
15.10.2012Reply to a communication from the examining division
13.09.2013Despatch of a communication from the examining division (Time limit: M06)
23.04.2014Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
23.06.2014Reply to a communication from the examining division
12.02.2015Communication of intention to grant the patent
12.06.2015Fee for grant paid
12.06.2015Fee for publishing/printing paid
15.06.2015Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  08.02.2010
Opposition(s)30.05.2016No opposition filed within time limit [2016/31]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
23.06.2014Request for further processing filed
23.06.2014Full payment received (date of receipt of payment)
Request granted
07.07.2014Decision despatched
The application is deemed to be withdrawn due to failure to reply to the examination report
15.10.2012Request for further processing filed
15.10.2012Full payment received (date of receipt of payment)
Request granted
30.10.2012Decision despatched
The application is deemed to be withdrawn due to failure to reply to the examination report
01.10.2010Request for further processing filed
01.10.2010Full payment received (date of receipt of payment)
Request granted
14.10.2010Decision despatched
Fees paidRenewal fee
15.10.2008Renewal fee patent year 03
31.03.2009Renewal fee patent year 04
18.03.2010Renewal fee patent year 05
12.04.2011Renewal fee patent year 06
30.03.2012Renewal fee patent year 07
29.03.2013Renewal fee patent year 08
24.09.2014Renewal fee patent year 09
31.03.2015Renewal fee patent year 10
Penalty fee
Additional fee for renewal fee
31.03.201106   M06   Fee paid on   26.08.2011
31.03.201409   M06   Fee paid on   24.09.2014
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU15.03.2006
AT26.08.2015
BE26.08.2015
BG26.08.2015
CY26.08.2015
CZ26.08.2015
DK26.08.2015
EE26.08.2015
ES26.08.2015
FI26.08.2015
IT26.08.2015
LT26.08.2015
LV26.08.2015
MC26.08.2015
NL26.08.2015
PL26.08.2015
RO26.08.2015
SE26.08.2015
SI26.08.2015
SK26.08.2015
TR26.08.2015
GR27.11.2015
IS26.12.2015
PT28.12.2015
IE15.03.2016
LU15.03.2016
[2018/38]
Former [2018/33]HU15.03.2006
AT26.08.2015
BE26.08.2015
CY26.08.2015
CZ26.08.2015
DK26.08.2015
EE26.08.2015
ES26.08.2015
FI26.08.2015
IT26.08.2015
LT26.08.2015
LV26.08.2015
MC26.08.2015
NL26.08.2015
PL26.08.2015
RO26.08.2015
SE26.08.2015
SI26.08.2015
SK26.08.2015
TR26.08.2015
GR27.11.2015
IS26.12.2015
PT28.12.2015
IE15.03.2016
LU15.03.2016
Former [2018/28]HU15.03.2006
AT26.08.2015
BE26.08.2015
CY26.08.2015
CZ26.08.2015
DK26.08.2015
EE26.08.2015
ES26.08.2015
FI26.08.2015
IT26.08.2015
LT26.08.2015
LV26.08.2015
MC26.08.2015
NL26.08.2015
PL26.08.2015
RO26.08.2015
SE26.08.2015
SI26.08.2015
SK26.08.2015
GR27.11.2015
IS26.12.2015
PT28.12.2015
IE15.03.2016
LU15.03.2016
Former [2017/07]AT26.08.2015
BE26.08.2015
CZ26.08.2015
DK26.08.2015
EE26.08.2015
ES26.08.2015
FI26.08.2015
IT26.08.2015
LT26.08.2015
LV26.08.2015
MC26.08.2015
NL26.08.2015
PL26.08.2015
RO26.08.2015
SE26.08.2015
SI26.08.2015
SK26.08.2015
GR27.11.2015
IS26.12.2015
PT28.12.2015
IE15.03.2016
LU15.03.2016
Former [2017/03]AT26.08.2015
BE26.08.2015
CZ26.08.2015
DK26.08.2015
EE26.08.2015
ES26.08.2015
FI26.08.2015
IT26.08.2015
LT26.08.2015
LV26.08.2015
MC26.08.2015
NL26.08.2015
PL26.08.2015
RO26.08.2015
SE26.08.2015
SI26.08.2015
SK26.08.2015
GR27.11.2015
IS26.12.2015
PT28.12.2015
LU15.03.2016
Former [2016/49]AT26.08.2015
CZ26.08.2015
DK26.08.2015
EE26.08.2015
ES26.08.2015
FI26.08.2015
IT26.08.2015
LT26.08.2015
LV26.08.2015
MC26.08.2015
NL26.08.2015
PL26.08.2015
RO26.08.2015
SE26.08.2015
SI26.08.2015
SK26.08.2015
GR27.11.2015
IS26.12.2015
PT28.12.2015
LU15.03.2016
BE31.03.2016
Former [2016/47]AT26.08.2015
CZ26.08.2015
DK26.08.2015
EE26.08.2015
ES26.08.2015
FI26.08.2015
IT26.08.2015
LT26.08.2015
LV26.08.2015
NL26.08.2015
PL26.08.2015
RO26.08.2015
SE26.08.2015
SI26.08.2015
SK26.08.2015
GR27.11.2015
IS26.12.2015
PT28.12.2015
LU15.03.2016
BE31.03.2016
Former [2016/36]AT26.08.2015
CZ26.08.2015
DK26.08.2015
EE26.08.2015
ES26.08.2015
FI26.08.2015
IT26.08.2015
LT26.08.2015
LV26.08.2015
NL26.08.2015
PL26.08.2015
RO26.08.2015
SE26.08.2015
SI26.08.2015
SK26.08.2015
GR27.11.2015
IS26.12.2015
PT28.12.2015
BE31.03.2016
Former [2016/23]AT26.08.2015
CZ26.08.2015
DK26.08.2015
EE26.08.2015
ES26.08.2015
FI26.08.2015
IT26.08.2015
LT26.08.2015
LV26.08.2015
NL26.08.2015
PL26.08.2015
RO26.08.2015
SE26.08.2015
SK26.08.2015
GR27.11.2015
IS26.12.2015
PT28.12.2015
Former [2016/22]AT26.08.2015
CZ26.08.2015
DK26.08.2015
EE26.08.2015
ES26.08.2015
FI26.08.2015
IT26.08.2015
LT26.08.2015
LV26.08.2015
NL26.08.2015
PL26.08.2015
SE26.08.2015
GR27.11.2015
IS26.12.2015
PT28.12.2015
Former [2016/21]AT26.08.2015
DK26.08.2015
ES26.08.2015
FI26.08.2015
IT26.08.2015
LT26.08.2015
LV26.08.2015
NL26.08.2015
PL26.08.2015
SE26.08.2015
GR27.11.2015
IS26.12.2015
PT28.12.2015
Former [2016/20]AT26.08.2015
DK26.08.2015
ES26.08.2015
FI26.08.2015
LT26.08.2015
LV26.08.2015
NL26.08.2015
PL26.08.2015
SE26.08.2015
GR27.11.2015
IS26.12.2015
PT28.12.2015
Former [2016/14]AT26.08.2015
ES26.08.2015
FI26.08.2015
LT26.08.2015
LV26.08.2015
NL26.08.2015
PL26.08.2015
SE26.08.2015
GR27.11.2015
IS26.12.2015
PT28.12.2015
Former [2016/11]AT26.08.2015
ES26.08.2015
FI26.08.2015
LT26.08.2015
LV26.08.2015
PL26.08.2015
SE26.08.2015
GR27.11.2015
IS26.12.2015
PT28.12.2015
Former [2016/10]ES26.08.2015
FI26.08.2015
LT26.08.2015
LV26.08.2015
PL26.08.2015
SE26.08.2015
GR27.11.2015
IS26.12.2015
PT28.12.2015
Former [2016/09]FI26.08.2015
LT26.08.2015
LV26.08.2015
GR27.11.2015
Former [2016/07]LT26.08.2015
Cited inInternational search[X]JP2004155707  ;
 [A]EP0138111  (CHIRON CORP [US]) [A] 1-39 * see abstract and sequences *;
 [A]WO9727217  (IST SUPERIORE SANITA [IT], et al) [A] 1-39 * see abstract, page 3 lines 26-34 and page 2 lines 32-36 *;
 [Y]WO9935247  (FRACTALES BIOTECH [FR], et al) [Y] 1,2,6-19,38 * see claims 1-5, page 3 line 13 to page 4 line 25 *;
 [XY]FR2852847  (ISOCELL [FR]) [X] 1,2,6,8,9,11-14,16,17,19,38 * see claims 1-15 *[Y] 1,2,6-19,38;
 [E]WO2006116452  (MOLECULAR REGENIX LLC [US], et al) [E] 1,2,6,8,9,11-19,38 * see claims 1-3 and 17, paragraphs [0011] and [0020]-[0022] *;
 [X]  - DATABASE WPI, 0, Derwent World Patents Index, vol. 2004, Database accession no. 2004-445177, XP002429982 & JP2004155707 A 20040603 (COMBI KK) [X] 1,2,6,8,9,11-19,38 * see abstract; column A *
 [XY]  - JOANNY MENVIELLE-BOURG F, "Superoxide dismutase (SOD), the powerful natural antioxidant, now available orally", PHYTOTHÉRAPIE ; DE LA RECHERCHE À LA PRATIQUE, SPRINGER-VERLAG, PA, (20050601), vol. 3, no. 3, ISSN 1765-2847, pages 118 - 121, XP019372632 [X] 1,2,6,8,9,11-19,38 * see abstract * [Y] 1,2,6-19,38

DOI:   http://dx.doi.org/10.1007/s10298-005-0087-9
 [X]  - VOULDOUKIS IOANNIS ET AL, "Antioxidant and anti-inflammatory properties of a Cucumis melo LC. extract rich in superoxide dismutase activity", JOURNAL OF ETHNOPHARMACOLOGY, ELSEVIER SCIENTIFIC PUBLISHERS LTD, IE, (200409), vol. 94, no. 1, ISSN 0378-8741, pages 67 - 75, XP002321961 [X] 1,2,6,8,9,11-19,38 * see abstract *

DOI:   http://dx.doi.org/10.1016/j.jep.2004.04.023
 [X]  - MURAI R ET AL, "SUPEROXIDE DISMUTASE [CU-ZN], CHLOROPLAST PRECURSOR (EC 1.15.1.1)", EMBL, (19981215), XP002337118 [X] 29,35 * see sequence *
by applicantJP2004155707
 FR2852847
    - "Superoxide dismutase (SOD), the powerful natural antioxidant, now available orally", JOANNY MENVIELLE-BOURG F, PHYTOTHERAPY ; DE LA RECHERCHE A LA PRATIQUE, SPRINGER-VERLAG, (20050601), vol. 3, pages 118 - 121
    - "Antioxidant and anti-inflammatory properties of a Cucumis melo LC extract nch in superoxide dismutase activity", VOULDOUKIS IOANNIS ET AL., JOURNAL OF ETHNOPHARMACOLOGY, ELSEVIER SCIENTIFIC PUBLISHERS, (200409), vol. 94, pages 67 - 75
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.